Profiles of tumor-infiltrating immune cells and prognostic genes associated with the microenvironment of bladder cancer

•Identifying TME-related DEGs based on immune and stromal scores of bladder cancer.•Establishment of an immune-related risk model for estimating patients’ outcomes.•Estimating the relative proportions of 22 TIICs in the TME using the CIBERSORT.•Effective components of tumor microenvironment could affect the clinical outcomes.